GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HeartSciences Inc (NAS:HSCS) » Definitions » Return-on-Tangible-Asset

HSCS (HeartSciences) Return-on-Tangible-Asset : -197.35% (As of Jan. 2025)


View and export this data going back to 2022. Start your Free Trial

What is HeartSciences Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. HeartSciences's annualized Net Income for the quarter that ended in Jan. 2025 was $-10.14 Mil. HeartSciences's average total tangible assets for the quarter that ended in Jan. 2025 was $5.14 Mil. Therefore, HeartSciences's annualized Return-on-Tangible-Asset for the quarter that ended in Jan. 2025 was -197.35%.

The historical rank and industry rank for HeartSciences's Return-on-Tangible-Asset or its related term are showing as below:

HSCS' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -240.44   Med: -194.84   Max: -117.94
Current: -125.15

During the past 5 years, HeartSciences's highest Return-on-Tangible-Asset was -117.94%. The lowest was -240.44%. And the median was -194.84%.

HSCS's Return-on-Tangible-Asset is ranked worse than
90.77% of 867 companies
in the Medical Devices & Instruments industry
Industry Median: -1.04 vs HSCS: -125.15

HeartSciences Return-on-Tangible-Asset Historical Data

The historical data trend for HeartSciences's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeartSciences Return-on-Tangible-Asset Chart

HeartSciences Annual Data
Trend Apr20 Apr21 Apr22 Apr23 Apr24
Return-on-Tangible-Asset
-194.84 -126.29 -240.44 -236.38 -117.94

HeartSciences Quarterly Data
Apr20 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -113.38 -86.13 -113.10 -130.34 -197.35

Competitive Comparison of HeartSciences's Return-on-Tangible-Asset

For the Medical Devices subindustry, HeartSciences's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HeartSciences's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeartSciences's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where HeartSciences's Return-on-Tangible-Asset falls into.


;
;

HeartSciences Return-on-Tangible-Asset Calculation

HeartSciences's annualized Return-on-Tangible-Asset for the fiscal year that ended in Apr. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Apr. 2024 )  (A: Apr. 2023 )(A: Apr. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Apr. 2024 )  (A: Apr. 2023 )(A: Apr. 2024 )
=-6.605/( (3.287+7.914)/ 2 )
=-6.605/5.6005
=-117.94 %

HeartSciences's annualized Return-on-Tangible-Asset for the quarter that ended in Jan. 2025 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Jan. 2025 )  (Q: Oct. 2024 )(Q: Jan. 2025 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Jan. 2025 )  (Q: Oct. 2024 )(Q: Jan. 2025 )
=-10.144/( (6.184+4.096)/ 2 )
=-10.144/5.14
=-197.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Jan. 2025) net income data.


HeartSciences  (NAS:HSCS) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


HeartSciences Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of HeartSciences's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


HeartSciences Business Description

Traded in Other Exchanges
N/A
Address
550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
Executives
David R. Wells director 2801 OCEAN PARK BLVD., SUITE 339, SANTA MONICA CA 90405
Bruce Bent director 750 BONHAM PARKWAY, LANTANA TX 76226
Mark T Hilz director, officer: See Remarks 3301 DAKOTA DRIVE, NORTHLAKE TX 76226
Patrick Kanouff director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Brian Szymczak director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Danielle Watson officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Andrew Simpson director, officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092